ACSM6 and bladder transitional cell carcinoma: Furthermore, the high ACSM6 group exhibited significantly higher enrichment scores for some immunosuppressive and carcinogenic pathways, including IDH1, WNT-β-catenin pathway, and PPARG co-expressed genes, suggesting the presence of a non-inflammatory TME in BLCA.